CTLA4 and head and neck squamous cell carcinoma: Ipilimumab treatment enhanced the CTX-mediated ADCC by eliminating Tregs (targeting CTLA-4), allowing effector T cell activation and restoration of the cytolytic functions of NK cells (n=6 HNSCC tumors) (188).